Playing with bone and fat

The relationship between bone and fat formation within the bone marrow microenvironment is complex and remains an area of active investigation. Classical in vitro and in vivo studies strongly support an inverse relationship between the commitment of bone marrow‐derived mesenchymal stem cells or stromal cells to the adipoctye and osteoblast lineage pathways. In this review, we focus on the recent literature exploring the mechanisms underlying these differentiation events and discuss their implications relevant to osteoporosis and regenerative medicine. J. Cell. Biochem. 98: 251–266, 2006. © 2006 Wiley‐Liss, Inc.

[1]  J. Gimble,et al.  Bone and fat , 2004, Endocrine.

[2]  R. Martin,et al.  Bone marrow fat content in relation to bone remodeling and serum chemistry in intact and ovariectomized dogs , 1990, Calcified Tissue International.

[3]  F. Guilak,et al.  Clonal analysis of the differentiation potential of human adipose‐derived adult stem cells , 2006, Journal of cellular physiology.

[4]  L. Suva,et al.  Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat. , 2006, Bone.

[5]  J. Glowacki,et al.  Adipocyte differentiation in Sod2(-/-) and Sod2(+/+) murine bone marrow stromal cells is associated with low antioxidant pools. , 2005, Experimental hematology.

[6]  R. Izadpanah,et al.  Characterization of multipotent mesenchymal stem cells from the bone marrow of rhesus macaques. , 2005, Stem cells and development.

[7]  B. Aronow,et al.  Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9. , 2005, Bone.

[8]  Thomas Benjamin,et al.  TAZ, a Transcriptional Modulator of Mesenchymal Stem Cell Differentiation , 2005, Science.

[9]  M. Lafage-Proust,et al.  Leptin modulates both resorption and formation while preventing disuse-induced bone loss in tail-suspended female rats. , 2005, Endocrinology.

[10]  M. Orth,et al.  Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice. , 2005, Endocrinology.

[11]  Caiying Guo,et al.  Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation , 2005, Nature Genetics.

[12]  Eijiro Watanabe,et al.  Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[13]  F. Guilak,et al.  Influence of oxygen on the proliferation and metabolism of adipose derived adult stem cells , 2005, Journal of cellular physiology.

[14]  J. Glowacki,et al.  Hypoxia Inhibition of Adipocytogenesis in Human Bone Marrow Stromal Cells Requires Transforming Growth Factor-β/Smad3 Signaling* , 2005, Journal of Biological Chemistry.

[15]  M. Hamrick,et al.  Leptin Treatment Induces Loss of Bone Marrow Adipocytes and Increases Bone Formation in Leptin‐Deficient ob/ob Mice , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  C. Dani,et al.  Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse , 2005, The Journal of experimental medicine.

[17]  J. Aubin,et al.  Estrogen Receptor-Related Receptor α: A Mediator of Estrogen Response in Bone , 2005 .

[18]  C. Ohlsson,et al.  Increased adipogenesis in bone marrow but decreased bone mineral density in mice devoid of thyroid hormone receptors. , 2005, Bone.

[19]  M. Macoritto,et al.  1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6). , 2005, American journal of physiology. Endocrinology and metabolism.

[20]  K. A. Wilson,et al.  Col1a1 Promoter-targeted Expression of p20 CCAAT Enhancer-binding Protein β (C/EBPβ), a Truncated C/EBPβ Isoform, Causes Osteopenia in Transgenic Mice* , 2005, Journal of Biological Chemistry.

[21]  J. Glowacki,et al.  Increased longevity of hematopoiesis in continuous bone marrow cultures and adipocytogenesis in marrow stromal cells derived from Smad3(-/-) mice. , 2005, Experimental hematology.

[22]  T. Yoneda,et al.  A CCAAT/Enhancer Binding Protein β Isoform, Liver-Enriched Inhibitory Protein, Regulates Commitment of Osteoblasts and Adipocytes , 2005, Molecular and Cellular Biology.

[23]  C. Robin,et al.  Mesenchymal progenitor cells localize within hematopoietic sites throughout ontogeny , 2005, Development.

[24]  A. Parfitt,et al.  Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. , 2005, Endocrinology.

[25]  O. Fromigué,et al.  Transforming growth factor-β inhibits CCAAT/enhancer-binding protein expression and PPARγ activity in unloaded bone marrow stromal cells , 2005 .

[26]  Jifeng Zhang,et al.  Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Aubin,et al.  Estrogen receptor-related receptor alpha: a mediator of estrogen response in bone. , 2005, The Journal of clinical endocrinology and metabolism.

[28]  G. Gronowicz,et al.  Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice. , 2005, The Journal of biological chemistry.

[29]  O. Fromigué,et al.  Transforming growth factor-beta inhibits CCAAT/enhancer-binding protein expression and PPARgamma activity in unloaded bone marrow stromal cells. , 2005, Experimental cell research.

[30]  Kozo Nakamura,et al.  Distinct effects of PPARγ insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells , 2005, Journal of Bone and Mineral Metabolism.

[31]  F. Jakob,et al.  Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation , 2005, Cell Communication and Signaling.

[32]  Moustapha Kassem,et al.  Induction of Adipocyte‐Like Phenotype in Human Mesenchymal Stem Cells by Hypoxia , 2004, Stem cells.

[33]  B. Lecka-Czernik,et al.  Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR‐γ2 transcription factor and TGF‐β/BMP signaling pathways , 2004, Aging cell.

[34]  G. Watkins,et al.  Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. , 2004, Endocrine-related cancer.

[35]  M. Bouxsein,et al.  Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. , 2004, Bone.

[36]  L. Pénicaud,et al.  Human bone marrow adipocytes support complete myeloid and lymphoid differentiation from human CD34+ cells , 2004, British journal of haematology.

[37]  Miya Ishihara,et al.  Osteogenic Potential of Human Adipose Tissue-Derived Stromal Cells as an Alternative Stem Cell Source , 2004, Cells Tissues Organs.

[38]  S. Farmer,et al.  Regulating the Balance between Peroxisome Proliferator-activated Receptor γ and β-Catenin Signaling during Adipogenesis , 2004, Journal of Biological Chemistry.

[39]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[40]  J. Auwerx,et al.  Enhanced bone formation in lipodystrophic PPARγhyp/hyp mice relocates haematopoiesis to the spleen , 2004, EMBO reports.

[41]  J. Peters,et al.  PPARβ/δ potentiates PPARγ‐stimulated adipocyte differentiation , 2004 .

[42]  J. Flier,et al.  Regulated Production of a Peroxisome Proliferator-activated Receptor-γ Ligand during an Early Phase of Adipocyte Differentiation in 3T3-L1 Adipocytes* , 2004, Journal of Biological Chemistry.

[43]  Y. Bae,et al.  Characterization and Expression Analysis of Mesenchymal Stem Cells from Human Bone Marrow and Adipose Tissue , 2004, Cellular Physiology and Biochemistry.

[44]  K. Seuwen,et al.  Enhanced Marrow Adipogenesis and Bone Resorption in Estrogen-Deprived Rats Treated with the PPARgamma Agonist BRL49653 (Rosiglitazone) , 2004, Calcified Tissue International.

[45]  J. Gimble,et al.  Human adipose-derived adult stem cells produce osteoid in vivo. , 2004, Tissue engineering.

[46]  M. Kassem,et al.  Subcutaneous adipocytes can differentiate into bone-forming cells in vitro and in vivo. , 2004, Tissue engineering.

[47]  F. Wezeman,et al.  Adipogenic effect of alcohol on human bone marrow-derived mesenchymal stem cells. , 2004, Alcoholism, clinical and experimental research.

[48]  J. Gimble,et al.  Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. , 2004, Current opinion in pharmacology.

[49]  T. Yanagawa,et al.  Induction of osteoblast differentiation indices by statins in MC3T3‐E1 cells , 2004, Journal of cellular biochemistry.

[50]  R. Tuan,et al.  Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  Su‐Li Cheng,et al.  Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis , 2004, Journal of Cell Science.

[52]  T. Jensen,et al.  Regulation of Human Skeletal Stem Cells Differentiation by Dlk1/Pref‐1 , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[53]  C. Löwik,et al.  The Balance Between Concurrent Activation of ERs and PPARs Determines Daidzein‐Induced Osteogenesis and Adipogenesis , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[54]  D. Shouhed,et al.  Oxysterols Regulate Differentiation of Mesenchymal Stem Cells: Pro‐Bone and Anti‐Fat , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[55]  Jong Bae Seo,et al.  Activated Liver X Receptors Stimulate Adipocyte Differentiation through Induction of Peroxisome Proliferator-Activated Receptor γ Expression , 2004, Molecular and Cellular Biology.

[56]  J. Seckl,et al.  Mice deficient in 11beta-hydroxysteroid dehydrogenase type 1 lack bone marrow adipocytes, but maintain normal bone formation. , 2004, Endocrinology.

[57]  Christopher S. Chen,et al.  Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. , 2004, Developmental cell.

[58]  R. Chiusaroli,et al.  ΔFosB Induces Osteosclerosis and Decreases Adipogenesis by Two Independent Cell-Autonomous Mechanisms , 2004, Molecular and Cellular Biology.

[59]  P. Tontonoz,et al.  Liver X receptors are regulators of adipocyte gene expression but not differentiation: identification of apoD as a direct target. , 2004, Journal of lipid research.

[60]  Kozo Nakamura,et al.  PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. , 2004, The Journal of clinical investigation.

[61]  D. Xie,et al.  Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. , 2004, Bone.

[62]  M. Macoritto,et al.  1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARγ2) , 2004, Experimental Gerontology.

[63]  F. Wezeman,et al.  Inhibitory effect of alcohol on osteogenic differentiation in human bone marrow-derived mesenchymal stem cells. , 2004, Alcoholism, clinical and experimental research.

[64]  T. Pennimpede,et al.  The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. , 2004, Endocrinology.

[65]  J. Glowacki,et al.  Cooperation Between TGF‐β and Wnt Pathways During Chondrocyte and Adipocyte Differentiation of Human Marrow Stromal Cells , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[66]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[67]  M. Macoritto,et al.  Vitamin D treatment of senescence accelerated mice (SAM-P/6) induces several regulators of stromal cell plasticity , 2004, Biogerontology.

[68]  J. Peters,et al.  PPARbeta/delta potentiates PPARgamma-stimulated adipocyte differentiation. , 2004, The FASEB Journal.

[69]  M. Macoritto,et al.  1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2). , 2004, Experimental gerontology.

[70]  S. Farmer,et al.  Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes. , 2004, The Journal of biological chemistry.

[71]  O. Fromigué,et al.  Plasticity and regulation of human bone marrow stromal osteoprogenitor cells: potential implication in the treatment of age-related bone loss. , 2004, Histology and histopathology.

[72]  L. Suva,et al.  Bone is a target for the antidiabetic compound rosiglitazone. , 2004, Endocrinology.

[73]  D. Rao,et al.  Intraclonal plasticity for bone, smooth muscle, and adipocyte lineages in bone marrow stroma fibroblastoid cells. , 2003, Experimental cell research.

[74]  D. Scadden,et al.  Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.

[75]  Haiyang Huang,et al.  Identification of the haematopoietic stem cell niche and control of the niche size , 2003, Nature.

[76]  J. Gimble.  Adipose tissue-derived therapeutics , 2003, Expert opinion on biological therapy.

[77]  G. Duque.  Will reducing adopogenesis in bone increase bone mass?: PPARgamma2 as a key target in the treatment of age-related bone loss. , 2003, Drug news & perspectives.

[78]  J. A. Robinson,et al.  High Bone Mass in Mice Expressing a Mutant LRP5 Gene , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[79]  F. Parhami.  Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor? , 2003, Prostaglandins, leukotrienes, and essential fatty acids.

[80]  T. Maeda,et al.  Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation. , 2003, Endocrinology.

[81]  J. Gustafsson,et al.  On the role of liver X receptors in lipid accumulation in adipocytes. , 2003, Molecular endocrinology.

[82]  Farshid Guilak,et al.  Differentiation potential of adipose derived adult stem (ADAS) cells. , 2003, Current topics in developmental biology.

[83]  Min Zhu,et al.  Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.

[84]  S. Khosla.  Leptin-central or peripheral to the regulation of bone metabolism? , 2002, Endocrinology.

[85]  F. Parhami,et al.  Role of the Cholesterol Biosynthetic Pathway in Osteoblastic Differentiation of Marrow Stromal Cells , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[86]  Patricia Ducy,et al.  Leptin Regulates Bone Formation via the Sympathetic Nervous System , 2002, Cell.

[87]  J Denton,et al.  Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis , 2002, Journal of clinical pathology.

[88]  J. Aubin,et al.  Estrogen receptor-related receptor alpha impinges on the estrogen axis in bone: potential function in osteoporosis. , 2002, Endocrinology.

[89]  J. Aubin,et al.  Differential Expression of Estrogen Receptor‐Related Receptor α and Estrogen Receptors α and β in Osteoblasts In Vivo and In Vitro , 2002 .

[90]  H. Sul,et al.  Mice Lacking Paternally Expressed Pref-1/Dlk1 Display Growth Retardation and Accelerated Adiposity , 2002, Molecular and Cellular Biology.

[91]  David E. Misek,et al.  Microarray Analyses during Adipogenesis: Understanding the Effects of Wnt Signaling on Adipogenesis and the Roles of Liver X Receptor α in Adipocyte Metabolism , 2002, Molecular and Cellular Biology.

[92]  J. Kirkland,et al.  Adipogenesis and aging: does aging make fat go MAD? , 2002, Experimental Gerontology.

[93]  Toshio Matsumoto,et al.  Estrogen Promotes Early Osteoblast Differentiation and Inhibits Adipocyte Differentiation in Mouse Bone Marrow Stromal Cell Lines That Express Estrogen Receptor (er) ␣ or ␤ , 2022 .

[94]  J. Lehmann,et al.  Printed in U.S.A. Copyright © 2002 by The Endocrine Society Divergent Effects of Selective Peroxisome Proliferator- Activated Receptor-�2 Ligands on Adipocyte Versus Osteoblast Differentiation , 2022 .

[95]  J. Lenhard,et al.  Select HIV Protease Inhibitors Alter Bone and Fat Metabolismex Vivo * , 2002, The Journal of Biological Chemistry.

[96]  Richard P Lifton,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[97]  Ivan Lobov,et al.  Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.

[98]  X. Holy,et al.  Transforming Growth Factor β2 Inhibits Adipocyte Differentiation Induced by Skeletal Unloading in Rat Bone Marrow Stroma , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[99]  T. Rando,et al.  Activation of an adipogenic program in adult myoblasts with age , 2002, Mechanisms of Ageing and Development.

[100]  Zhong Yun,et al.  Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. , 2002, Developmental cell.

[101]  M. Karperien,et al.  Exposure of KS483 Cells to Estrogen Enhances Osteogenesis and Inhibits Adipogenesis , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[102]  G. Duque,et al.  Age-Related Bone Loss: Old Bone, New Facts , 2002, Gerontology.

[103]  J. Lehmann,et al.  Divergent Effects of Selective Peroxisome Proliferator-Activated Receptor- (cid:1) 2 Ligands on Adipocyte Versus Osteoblast Differentiation , 2002 .

[104]  Mark L. Johnson,et al.  A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. , 2002, American journal of human genetics.

[105]  Toshio Matsumoto,et al.  Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. , 2002, Endocrinology.

[106]  S. Gerson,et al.  Adult bone marrow stem cells for cell and gene therapies: Implications for greater use , 2002, Journal of cellular biochemistry. Supplement.

[107]  J. Aubin,et al.  Differential expression of estrogen receptor-related receptor alpha and estrogen receptors alpha and beta in osteoblasts in vivo and in vitro. , 2002, Journal of Bone and Mineral Research.

[108]  C. Hartmann,et al.  Cbfa 1-independent decrease in osteoblast proliferation , osteopenia , and persistent embryonic eye vascularization in mice deficient in Lrp 5 , a Wnt coreceptor , 2002 .

[109]  W. Wilkison,et al.  Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. , 2001, Tissue engineering.

[110]  Miikka Vikkula,et al.  LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.

[111]  T Kobayashi,et al.  Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. , 2001, Genes & development.

[112]  M. Kassem,et al.  [Mesenchymal stem cells. Potential use in cell and gene therapy of bone loss caused by aging and osteoporosis]. , 2001, Ugeskrift for laeger.

[113]  F. Wezeman,et al.  Bone marrow triglyceride accumulation and hormonal changes during long-term alcohol intake in male and female rats. , 2001, Alcoholism, clinical and experimental research.

[114]  J. Glowacki,et al.  Age‐related decline in the osteogenic potential of human bone marrow cells cultured in three‐dimensional collagen sponges , 2001, Journal of cellular biochemistry.

[115]  H. Schöler,et al.  Oct‐4: Gatekeeper in the Beginnings of Mammalian Development , 2001, Stem cells.

[116]  E. Falk,et al.  Troglitazone Treatment Increases Bone Marrow Adipose Tissue Volume but Does not Affect Trabecular Bone Volume in Mice , 2001, Calcified Tissue International.

[117]  A. Caplan,et al.  Cultivation of rat marrow‐derived mesenchymal stem cells in reduced oxygen tension: Effects on in vitro and in vivo osteochondrogenesis , 2001, Journal of cellular physiology.

[118]  J. Aubin,et al.  The Orphan Nuclear Estrogen Receptor–Related Receptor α (Errα) Is Expressed Throughout Osteoblast Differentiation and Regulates Bone Formation in Vitro , 2001, The Journal of cell biology.

[119]  W. Wilkison,et al.  Thiazolidinediones and glucocorticoids synergistically induce differentiation of human adipose tissue stromal cells: biochemical, cellular, and molecular analysis. , 2001, Metabolism: clinical and experimental.

[120]  H. Lorenz,et al.  Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.

[121]  T. Maeda,et al.  Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. , 2001, Biochemical and biophysical research communications.

[122]  J. Gimble,et al.  Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? , 2000, Bone.

[123]  J. Glowacki,et al.  Age-related decline in osteoprotegerin expression by human bone marrow cells cultured in three-dimensional collagen sponges. , 2000, Biochemical and biophysical research communications.

[124]  Arndt F Schilling,et al.  Leptin Inhibits Bone Formation through a Hypothalamic Relay A Central Control of Bone Mass , 2000, Cell.

[125]  S. Harris,et al.  Stimulation of bone formation in vitro and in rodents by statins. , 1999, Science.

[126]  N. Nardi,et al.  The hematopoietic stroma. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[127]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[128]  M. Jensen,et al.  Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. , 1999, Endocrinology.

[129]  V. Goldberg,et al.  The Effect of Implants Loaded with Autologous Mesenchymal Stem Cells on the Healing of Canine Segmental Bone Defects* , 1998, The Journal of bone and joint surgery. American volume.

[130]  J. Glowacki,et al.  In vitro secretion of cytokines by human bone marrow: effects of age and estrogen status. , 1998, The Journal of clinical endocrinology and metabolism.

[131]  M. Nuttall,et al.  Human Trabecular Bone Cells Are Able to Express Both Osteoblastic and Adipocytic Phenotype: Implications for Osteopenic Disorders , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[132]  A. Parfitt,et al.  Increased Adipogenesis and Myelopoiesis in the Bone Marrow of SAMP6, a Murine Model of Defective Osteoblastogenesis and Low Turnover Osteopenia , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[133]  H. Sul,et al.  Cleavage of membrane-associated pref-1 generates a soluble inhibitor of adipocyte differentiation , 1997, Molecular and cellular biology.

[134]  J. Lehmann,et al.  Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. , 1996, Molecular pharmacology.

[135]  J. Gimble,et al.  The function of adipocytes in the bone marrow stroma: an update. , 1996, Bone.

[136]  D. Mangelsdorf,et al.  An oxysterol signalling pathway mediated by the nuclear receptor LXRα , 1996, Nature.

[137]  C. Koch,et al.  Adaptation of chondrocytes to low oxygen tension: Relationship between hypoxia and cellular metabolism , 1996, Journal of cellular physiology.

[138]  J. Gimble,et al.  Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells , 1995, Journal of cellular biochemistry.

[139]  K. Umesono,et al.  LXR, a nuclear receptor that defines a distinct retinoid response pathway. , 1995, Genes & development.

[140]  K. Medina,et al.  Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[141]  R. Taichman,et al.  Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor , 1994, The Journal of experimental medicine.

[142]  H. Sul,et al.  Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation , 1993, Cell.

[143]  J. Gimble,et al.  Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells , 1993, Journal of cellular physiology.

[144]  J. Greenberger,et al.  Adipogenesis in a myeloid supporting bone marrow stromal cell line , 1992, Journal of cellular biochemistry.

[145]  C. Devlin,et al.  Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. , 1992, Journal of cell science.

[146]  R. Martin,et al.  Relationships between marrow fat and bone turnover in ovariectomized and intact rats. , 1991, Bone.

[147]  J. Gimble.  The function of adipocytes in the bone marrow stroma. , 1990, The New biologist.

[148]  J. Gimble,et al.  Adipogenesis in a murine bone marrow stromal cell line capable of supporting B lineage lymphocyte growth and proliferation: Biochemical and molecular characterization , 1990, European journal of immunology.

[149]  J. Gimble,et al.  Cells and molecules that regulate B lymphopoiesis in bone marrow. , 1989, Annual review of immunology.

[150]  M. Tavassoli.  Marrow adipose cells and hemopoiesis: an interpretative review. , 1984, Experimental hematology.

[151]  P Meunier,et al.  Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. , 1971, Clinical orthopaedics and related research.

[152]  C S PETTY,et al.  NORMAL VARIATIONS WITH AGING OF THE AMOUNT OF HEMATOPOIETIC TISSUE IN BONE MARROW FROM THE ANTERIOR ILIAC CREST. A STUDY MADE FROM 177 CASES OF SUDDEN DEATH EXAMINED BY NECROPSY. , 1965, American journal of clinical pathology.

[153]  A. Vost.  OSTEOPOROSIS: A NECROPSY STUDY OF VERTEBRAE AND ILIAC CRESTS. , 1963, The American journal of pathology.

[154]  R. Custer,et al.  Studies on the structure and function of bone marrow , 1932 .